Bio-Rad [BIO.B] vs Masimo [MASI] Detailed Stock Comparison
Bio-Rad
NYSE
Loading...
Masimo
NASDAQ
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Bio-Rad wins in 13 metrics, Masimo wins in 6 metrics, with 0 ties. Bio-Rad appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Bio-Rad | Masimo | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 25.71 | 129.16 | Bio-Rad |
| Price-to-Book Ratio | 1.08 | 7.67 | Bio-Rad |
| Debt-to-Equity Ratio | 19.73 | 61.58 | Bio-Rad |
| PEG Ratio | -0.22 | 0.60 | Bio-Rad |
| EV/EBITDA | 18.87 | 55.23 | Bio-Rad |
| Profit Margin (TTM) | 12.50% | -21.32% | Bio-Rad |
| Operating Margin (TTM) | 12.19% | 17.12% | Masimo |
| EBITDA Margin (TTM) | 12.19% | 17.12% | Masimo |
| Return on Equity | 4.59% | -22.37% | Bio-Rad |
| Return on Assets (TTM) | 1.59% | 1.84% | Masimo |
| Free Cash Flow (TTM) | $266.20M | $145.30M | Bio-Rad |
| 1-Year Return | -14.92% | 5.34% | Masimo |
| Price-to-Sales Ratio (TTM) | 3.10 | 3.72 | Bio-Rad |
| Enterprise Value | $7.74B | $8.49B | Masimo |
| EV/Revenue Ratio | 3.03 | 3.94 | Bio-Rad |
| Gross Profit Margin (TTM) | 52.99% | 62.90% | Masimo |
| Revenue per Share (TTM) | $92 | $40 | Bio-Rad |
| Earnings per Share (Diluted) | $11.08 | $-5.10 | Bio-Rad |
| Beta (Stock Volatility) | 0.97 | 1.28 | Bio-Rad |
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends
Bio-Rad vs Masimo Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Bio-Rad | 10.00% | 0.00% | 15.31% | 13.92% | 17.72% | -12.51% |
| Masimo | 1.43% | 3.63% | -0.44% | -8.82% | -1.48% | -12.13% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Bio-Rad | -14.92% | -36.76% | -46.25% | 111.13% | 215.90% | 430.01% |
| Masimo | 5.34% | 11.94% | -37.58% | 261.29% | 411.85% | 639.91% |
News Based Sentiment: Bio-Rad vs Masimo
Bio-Rad
News based Sentiment: NEGATIVE
Bio-Rad reported a slight decrease in both revenue and earnings per share for the first quarter of 2024. While not a dramatic decline, this signals potential challenges and warrants investor attention, making it an important, though not game-changing, development.
Masimo
News based Sentiment: MIXED
Masimo experienced a significant restructuring with the sale of Sound United, leading to recasted financials. While analyst ratings are mixed, with upgrades and cautious outlooks, positive earnings estimates and insider buying suggest underlying confidence. This combination of events makes October a noteworthy month for investors.
Performance & Financial Health Analysis: Bio-Rad vs Masimo
| Metric | BIO.B | MASI |
|---|---|---|
| Market Information | ||
| Market Cap | $8.41B | $8.00B |
| Market Cap Category | Mid cap | Mid cap |
| 10 Day Avg. Volume | 40 | 676,210 |
| 90 Day Avg. Volume | 15 | 651,863 |
| Last Close | $313.36 | $150.25 |
| 52 Week Range | $225.29 - $359.22 | $133.17 - $194.88 |
| % from 52W High | -12.77% | -22.90% |
| All-Time High | $818.60 (Sep 06, 2021) | $305.21 (Nov 15, 2021) |
| % from All-Time High | -61.72% | -50.77% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.02% | 0.08% |
| Quarterly Earnings Growth | 0.02% | 2.21% |
| Financial Health | ||
| Profit Margin (TTM) | 0.13% | -0.21% |
| Operating Margin (TTM) | 0.12% | 0.17% |
| Return on Equity (TTM) | 0.05% | -0.22% |
| Debt to Equity (MRQ) | 19.73 | 61.58 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $263.42 | $19.20 |
| Cash per Share (MRQ) | $50.76 | $2.75 |
| Operating Cash Flow (TTM) | $534.20M | $176.60M |
| Levered Free Cash Flow (TTM) | $223.40M | $92.86M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | $0.00 |
Valuation & Enterprise Metrics Analysis: Bio-Rad vs Masimo
| Metric | BIO.B | MASI |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 25.71 | 129.16 |
| Forward P/E | N/A | 31.74 |
| PEG Ratio | -0.22 | 0.60 |
| Price to Sales (TTM) | 3.10 | 3.72 |
| Price to Book (MRQ) | 1.08 | 7.67 |
| Market Capitalization | ||
| Market Capitalization | $8.41B | $8.00B |
| Enterprise Value | $7.74B | $8.49B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 3.03 | 3.94 |
| Enterprise to EBITDA | 18.87 | 55.23 |
| Risk & Other Metrics | ||
| Beta | 0.97 | 1.28 |
| Book Value per Share (MRQ) | $263.42 | $19.20 |
Financial Statements Comparison: Bio-Rad vs Masimo
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | BIO.B | MASI |
|---|---|---|
| Revenue/Sales | $585.40M | $372.00M |
| Cost of Goods Sold | $279.40M | $138.00M |
| Gross Profit | $306.00M | $234.00M |
| Research & Development | $73.50M | $33.90M |
| Operating Income (EBIT) | $23.70M | $80.70M |
| EBITDA | $98.50M | $90.70M |
| Pre-Tax Income | $83.40M | $68.40M |
| Income Tax | $19.40M | $21.20M |
| Net Income (Profit) | $64.00M | $-170.70M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | BIO.B | MASI |
|---|---|---|
| Cash & Equivalents | $521.40M | $130.80M |
| Total Current Assets | $3.04B | $1.18B |
| Total Current Liabilities | $506.60M | $546.50M |
| Long-Term Debt | $1.33B | $657.70M |
| Total Shareholders Equity | $6.68B | $946.40M |
| Retained Earnings | $7.48B | $1.32B |
| Property, Plant & Equipment | $681.70M | $183.60M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | BIO.B | MASI |
|---|---|---|
| Operating Cash Flow | $156.00M | $62.60M |
| Capital Expenditures | $-34.40M | $17.00M |
| Free Cash Flow | $95.50M | $27.00M |
| Debt Repayment | $-100,000 | $-78.80M |
| Common Stock Repurchase | $-101.90M | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | BIO.B | MASI |
|---|---|---|
| Shares Short | 24 | 3.72M |
| Short Ratio | N/A | 6.13 |
| Short % of Float | 0.00% | 0.10% |
| Average Daily Volume (10 Day) | 40 | 676,210 |
| Average Daily Volume (90 Day) | 15 | 651,863 |
| Shares Outstanding | 28.01M | 53.60M |
| Float Shares | 21.67M | 46.46M |
| % Held by Insiders | 0.98% | 0.06% |
| % Held by Institutions | 0.00% | 1.10% |
Dividend Analysis & Yield Comparison: Bio-Rad vs Masimo
| Metric | BIO.B | MASI |
|---|---|---|
| Last 12-Month Dividend | N/A | $0.00 |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | $0.00 |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | N/A | $0.00 |
| Ex-Dividend Date | N/A | N/A |